TrialDiabetes care2013

Once-weekly exenatide versus once- or twice-daily insulin detemir: randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas.

Melanie Davies et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.